Table 1 Comparison of general information
Observation group | Control group | P-value | ||
|---|---|---|---|---|
Gender | Male | 33 (97.06%) | 30 (83.33%) | 0.107 |
Female | 1 (2.94%) | 6 (16.67%) | ||
Age | 64.56 ± 6.805 | 67.64 ± 7.337 | 0.073 | |
Tumor location | Upper thoracic | 5 (14.71%) | 1 (2.78%) | 0.239 |
Middle thoracic | 20 (58.82%) | 25 (69.44%) | ||
Lower thoracic | 9 (26.47%) | 10 (27.78%) | ||
Clinical stage | IIIA | 0 | 5 (13.89%) | 0.239 |
IIIB | 27 (79.41%) | 31 (86.11%) | ||
IVA | 7 (20.59%) | 0 | ||
Pathology type | Ulceratice | 23 (67.65%) | 23 (63.89%) | 0.725 |
Mushroom | 5 (14.71%) | 3 (8.33%) | ||
Constrictive | 5 (14.71%) | 9 (25.00%) | ||
Medullary | 1 (2.94%) | 1 (2.78%) | ||
Surgical approach | Ivor-Lewis | 9 (26.47%) | 10 (27.78%) | 0.210 |
McKeown | 25 (73.53%) | 26 (72.22%) | ||
Lymph node dissection | Two-field | 9 (26.47%) | 10 (27.78%) | 0.210 |
Three-field | 25 (73.53%) | 26 (72.22%) | ||
Anastomosis | Cervical | 25 (73.53%) | 26 (72.22%) | 0.210 |
Thoracic | 9 (26.47%) | 10 (27.78%) |